» Articles » PMID: 23620859

Surveillance of Multidrug Resistant Uropathogenic Bacteria in Hospitalized Patients in Indian

Overview
Specialty Tropical Medicine
Date 2013 Apr 27
PMID 23620859
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To record surveillance, antibiotic resistance of uropathogens of hospitalized patients over a period of 18 months.

Methods: Urine samples from wards and cabins were used for isolating urinary tract infection (UTI)-causing bacteria that were cultured on suitable selective media and identified by biochemical tests; and their antibiograms were ascertained by Kirby-Bauer's disc diffusion method, in each 6-month interval of the study period, using 18 antibiotics of five different classes.

Results: From wards and cabins, 1 245 samples were collected, from which 996 strains of bacteria belonging to 11 species were isolated, during April 2011 to September 2012. Two Gram-positive, Staphylococcus aureus (S. aureus) and Enterococcus faecalis (E. faecalis), and nine Gram-negative bacteria, Acinetobacter baumannii, Citrobacter sp., Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis, Proteus vulgaris and Pseudomonas aeruginosa were isolated. Both S. aureus and E. faecalis were vancomycin resistant, and resistant-strains of all pathogens increased in each 6-month period of study. Particularly, all Gram-negatives were resistant to nitrofurantoin and co-trimoxazole, the most preferred antibiotics of empiric therapy for UTI.

Conclusions: Antibiograms of 11 UTI-causing bacteria recorded in this study indicated moderately higher numbers of strains resistant to each antibiotic studied, generating the fear of precipitating fervent episodes in public health particularly with bacteria, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and S. aureus. Moreover, vancomycin resistance in strains of S. aureus and E. faecalis is a matter of concern.

Citing Articles

Exploring the Dynamic Role of Bacterial Etiology in Complicated Urinary Tract Infections.

Guliciuc M, Porav-Hodade D, Mihailov R, Rebegea L, Voidazan S, Ghirca V Medicina (Kaunas). 2023; 59(9).

PMID: 37763805 PMC: 10538164. DOI: 10.3390/medicina59091686.


Association of Virulence Markers With Resistance to Oral Antibiotics in Escherichia coli Isolates Causing Uncomplicated Community-Acquired Cystitis.

Radera S, Agarwal J, Srivastava S, Gupta P, Pandey A Cureus. 2023; 15(5):e39458.

PMID: 37362452 PMC: 10290217. DOI: 10.7759/cureus.39458.


Emergence of microbial infections in some hospitals of Cairo, Egypt: studying their corresponding antimicrobial resistance profiles.

Helmy A, Sidkey N, El-Badawy R, Hegazi A BMC Infect Dis. 2023; 23(1):424.

PMID: 37349674 PMC: 10286371. DOI: 10.1186/s12879-023-08397-4.


Antibiotic-resistant pathogenic bacterial isolates from patients attending the outpatient department of university of Cape Coast hospital, Ghana: A retrospective study between 2013-2015.

Asare K, Amoah S, Coomson Jr C, Banson C, Yaro D, Mbata J PLOS Glob Public Health. 2023; 2(5):e0000417.

PMID: 36962199 PMC: 10021532. DOI: 10.1371/journal.pgph.0000417.


Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates.

Wu Q, Sabokroo N, Wang Y, Hashemian M, Karamollahi S, Kouhsari E Antimicrob Resist Infect Control. 2021; 10(1):101.

PMID: 34193295 PMC: 8247230. DOI: 10.1186/s13756-021-00967-y.


References
1.
Eliopoulos G . Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J Infect. 2009; 59 Suppl 1:S17-24. DOI: 10.1016/S0163-4453(09)60004-9. View

2.
Taneja N, Chatterjee S, Singh M, Singh S, Sharma M . Pediatric urinary tract infections in a tertiary care center from north India. Indian J Med Res. 2010; 131:101-5. View

3.
DAndrea M, Venturelli C, Giani T, Arena F, Conte V, Bresciani P . Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases. J Clin Microbiol. 2011; 49(7):2755-8. PMC: 3147842. DOI: 10.1128/JCM.00016-11. View

4.
Ferrari R, Magnani M, Souza R, Tognim M, Oliveira T . Mutant prevention concentration (MPC) of ciprofloxacin against Salmonella enterica of epidemic and poultry origin. Curr Microbiol. 2010; 62(2):628-32. DOI: 10.1007/s00284-010-9754-7. View

5.
Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View